Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis

Cited by (803)

Items 701–800 of 803

1. Recent Advancement of Tubercular Therapy in MDR-TB and DR-TB
   Fiza Patel, Sushant Benade, Shraddha Nerkar, Priyanka Gavhade, Sheetal Rode, Ashoke Giri · 2025 · International Journal for Research in Applied Science and Engineering Technology
2. Tuberculosis and humans: Till death do us part?
   Olatunde Ayodeji Olayanju, Izuchukwu N. Mba, Gabriel Nku Odok Jr, Nnaemeka Elvis Awah, Samuel Miracle Ebiowe, Ijeoma P. Ucheobi · 2025 · Egyptian Journal of Chest Diseases and Tuberculosis
3. Overweight and obesity as emerging risk factors for multidrug-resistant tuberculosis (MDR-TB): a systematic review and meta-analysis
   Edinson Dante Meregildo-Rodríguez, Gabriela Campos-Silva, Martha Genara Asmat-Rubio, Gustavo Adolfo Vásquez-Tirado, Karen Evelyn Ramos-Rodríguez · 2025 · Research Square
4. Peptide Molecular Siege Machine: Breaking through Mycobacterium tuberculosis’s Cellular Defenses for Precise Detection and Monitoring
   Wenting Cheng, Yuanyuan Miao, Chuang Wang, Yanwen Zu, Zhisong Wu, Yongchen Zhang, Jinlong Li · 2025 · Analytical Chemistry
5. Recent gene therapy approaches for the treatment of tuberculosis
   Nimisha Srivastava, Emamezi Samuel · 2025 · Elsevier eBooks
6. Factores asociados a la adherencia terapéutica y desenlaces clínicos en pacientes con tuberculosis en el Departamento del Atlántico, Colombia (2021-2023)
   Miguel Ángel Herrera-Olivares, Anabell Donado Mercado, Rafael Morales-González, Magda Pérez-Villanueva, Alex Domínguez-Vargas, Henry Joseth González-Torres · 2025 · Infectio
7. Experiences of children and their caregivers affected by multidrug-resistant tuberculosis in Cape Town, South Africa
   Abenathi Mcinziba, Dillon T. Wademan, Klassina Zimri, Stephanie Jacobs, Khanyisa Mcimeli, Hendrik Simon Schaaf, Anneke Catharina Hesseling, James A. Seddon, Thomas Wilkinson, Graeme Hoddinott · 2025 · PLoS ONE
8. Novel Isatin-Chalcone Derivatives: Synthesis, Characterization and Evaluation for Antimicrobial and Anticancer Applications
   Marapatla Shiny, Girija Sastry Vedula · 2025 · Asian Journal of Chemistry
9. Extra-pulmonary Tuberculosis Diagnostic Dilemma in an Immunocompetent Patient – A Case Report
   Anjali Patond, Vijayshri Suresh Deotale, Ruchita Attal · 2025 · Journal of Pure and Applied Microbiology
10. Uncovering Potential Inhibitors of Mycobacterium Tuberculosis Eis Protein: Insights from Virtual Screening and Molecular Dynamics
    Ramasamy Thilagavathi, M. Gowrisankar, M. B. Aakila Banu, P. Kaviya, Y. Ranjith, S. M. Ram Balaji, Kandhan Palanisamy, S. M. Esther Rubavathy, Muthuramalingam Prakash, Chelliah Selvam · 2025 · ChemistrySelect
11. Education on Assistance for Drug-Resistant TB Patients Since Diagnosis to Community TB Cadres Through Cadre Training Activities in Kediri City in 2025
    Nurita Nilasari Bunga Kharisma Arifiana Putri, Heny Kristanto, Yunarsih Yunarsih, Sucipto Sucipto, Puguh Santoso, Betristasia Puspitasari · 2025 · Journal of Community Service for Health
12. Sulfonated Hydroxyxanthone as Anti-Tuberculosis Agent: One-Step Sequence Synthesis, Characterization, And Molecular Docking Preevaluation
    Emmy Yuanita, Ima Arum Lestarini, Ni Komang Tri Dharmayani, Baiq Nila Sari Ningsih, Maulida Septiyana, Maria Ulfa, Sudirman Sudirman, Taufan Hari Sugara · 2025 · Jordan Journal of Pharmaceutical Sciences
13. A scoping review exploring the role of homoeopathic drugs as a host directed therapy in the management of drug-resistant tuberculosis
    Bhargav Sarma K, Vaishali Vasant Dolas, Vijay Nema · 2025 · Advances in Integrative Medicine
14. Design, Synthesis, and Evaluation of Nitroimidazole N-arylacetamides as Anti-TB Agents
    Nadim Chhipa, Pinkal H. Patel, Umang Shah · 2025 · Current Bioactive Compounds
15. Role of Transcription Factor NR1H3 in the Pathogenesis of Tuberculosis
    Anju Kumari, Rajwinder Kaur · 2025 · Biology Bulletin Reviews
16. Mycobacterium tuberculosis methyltransferases as alternative strategies to combat drug resistant tuberculosis
    Kashish Choudhary, Sana Tanweer, Mohd Zaid Choudhary, Sonam Grover · 2025 · International Journal of Biological Macromolecules
17. Evaluation of the Activity of Amoxicillin/Clavulanate, Ceftazidime/Avibactam and Colistin Against Drug-Resistant Mycobacterium tuberculosis Isolates by the E-test Method
    Cemilenur Ataş, Tuba Astarcioglu, Kübra Yıldırım, Mehmet Akif Gün, Emel Cengiz Kaynakci, Deniz Turgut Coban, Ahmet Yılmaz Çoban · 2025 · Jundishapur Journal of Microbiology
18. Prediction of microbe-drug associations using a CNN-Bernoulli random forest model
    Zihao Song, Qingnuo Li, Jincheng Zhao, Qinggang Bu, Zekang Bian, Jia Qu · 2025 · PeerJ
19. Mycobacterium tuberculosis: Recent Advances in Drug Discovery and Targets – A SAR-Based Approach
    Krupanshi Bharadava, Aviral Kaushik, Nigam Vyas, Tarun Kumar Upadhyay, C. Ratna Prabha, Radhey Shyam Kaushal · 2025 · BENTHAM SCIENCE PUBLISHERS eBooks
20. QUANTIFICATION OF PYRAZINAMIDE IN HUMAN PLASMA: DEVELOPMENT AND VALIDATION OF A LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY METHOD
    Erica Alves, Celina Nazareth, Raman Batheja, Reuben Nazareth · 2025 · INDIAN DRUGS
21. Reimagining the Transition of Mycobacterium Tuberculosis Research from Mammalian Models to Zebrafish
    Gaurav Sharma · 2024 · Vidhyayana
22. Integrative Approaches to Treat Tuberculosis
    Yashodhara Goswami, Yugal Kishore Mohanta, Ishani Chakrabartty · 2025 · Advances in Integrative Medicine
23. Systems Immunology and Omics Data from Developing Countries Are Needed to Inform Vaccine Development
    Tufária Mussá · 2025 · Springer eBooks
24. PPARγ mediated enhanced lipid biogenesis fuels Mycobacterium tuberculosis growth in a drug-tolerant hepatocyte environment
    Binayak Sarkar, Jyotsna Jyotsna, Mohit Yadav, Priya Sharma, Raman Deep Sharma, Shweta Singh, Aakash Chandramouli, Kritee Mehdiratta, Ashwani Kumar, Siddhesh S. Kamat et al. · 2025 · eLife
25. Factors contributing to multidrug-resistant tuberculosis among sputum culture-positive pulmonary tuberculosis patients in Indonesia: A cross-sectional study
    Dina Bisara Lolong, Joko Irianto, Ina Kusrini, Ingan Ukur Tarigan, Alfons Maryono Letelay, Kristina Tobing, Maria Holly Herawati, Noer Endah Pracoyo, Siti Isfandari, Raflizar et al. · 2025 · Asian Pacific Journal of Tropical Medicine
26. Molecular Detection of Multi-drug Resistant Tuberculosis in Clinical Isolates from Two Urban Centres in Malawi
    Tionge Sikwese, Takondwa Charles Msosa, Hussein Hassan Twabi, Samuel Dzunda, David Chaima, Billy Banda, Yusuf Kanamazina, Mirriam Ethel Nyenje, Alinune Musopole, Marriott Nliwasa et al. · 2025 · Archives of Clinical and Biomedical Research
27. Bioactive metabolites from Curcuma amada as anti-tubercular agents
    Pooja Yadav, Siddharth Singh, Priyanshi Dwivedi, Rajesh Tiwari, Mala Trivedi · 2025 · Medicinal Plants - International Journal of Phytomedicines and Related Industries
28. Marine microbial resources: Under explored resource for anti-TB drug discovery
    Asmita Dhimmar, Harshal Sahastrabudhe, Apexa Gajjar, Pooja Vishwakarma, Usha P. Shinde, Jignesh Doshi, Pramod B. Shinde · 2025 · Elsevier eBooks
29. Effectiveness of telemedicine interventions for the management of tuberculosis in low- and middle-income countries: a systematic review protocol
    Diana Dalisay Orolfo, Fredyrose Ivan L. Pinar, Alely S. Reyes · 2025 · JBI Evidence Synthesis
30. Comparative genomic analysis of drug-resistant and drug-sensitive tuberculosis strains and their impact on cough severity
    Malik Olatunde Oduoye, Hiba Zafar, Umer Wamiq, Suheera Afzoon, Hafsa Shuja, Oluwapelumi Wumi Adeniji, Abdulmumeen Ibrahim Opeyemi · 2025 · Mycobacteria
31. In silico identification of potential inhibitors of Mycobacterium tuberculosis DNA gyrase from Phytoconstituents of Indian medicinal plants
    Janmejaya Rout, Sayani Das, Sandip Kaledhonkar · 2025 · Computers in Biology and Medicine
32. Magnitude of poor multidrug-resistant tuberculosis treatment outcome among multidrug-resistant tuberculous patients at tertiary hospital, South West Ethiopia
    Gemechu Gelana Ararame, Hailegabreil Nardos · 2025 · Annals of Clinical Microbiology and Antimicrobials
33. Contributions of Community Advisory Board and Experience of Study Participants in TB/MDR‐TB Clinical Trial Management in Addis Ababa, Ethiopia: A Qualitative Study
    Yemisrach Seralegne, Abaraham G Medihin, Ermiyas Hundito, Hawult Adane, Bizunesh Sintayehu · 2025 · Developing World Bioethics
34. Additional file 1 of Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis
    Pai, Helen, Norbert O. Ndjeka, Lawrence Mbuagbaw, Koné Kaniga, Eileen Birmingham, Gary Mao, Lori Alquier, Kourtney J. Davis, Arianne Bodard, Abeda Williams et al. · 2022 · Figshare
35. Additional file 1 of Brazilian cohort study of risk factors associated with unsuccessful outcomes of drug resistant tuberculosis
    Patrícia Bartholomay, Rejane Sobrino Pinheiro, Fernanda Dockhorn Costa Johansen, Daniele Maria Pelissari, de Araújo, Wildo Navegantes · 2021 · Figshare
36. Additional file 1 of Association between HIV and acquisition of rifamycin resistance with first-line TB treatment: a systematic review and meta-analysis
    Nesbert Zinyakatira, Ford, Nathan, Helen Cox · 2024 · Figshare
37. Evaluation of tuberculosis education effects on healthcare workers’ knowledge attitudes and practices in Jiangsu China 2019 to 2023
    Dian Jia, Honghuan Song, G L Li, Jinshui Xu, Limei Zhu, Yan Li · 2025 · Scientific Reports
38. Success Stories of QSAR Methods in Drug Design
    Igor Henrique Sanches, Melina Mottin, Wemenes J. L. Silva, Carolina Horta Andrade · 2025 · Springer handbooks
39. Drug Resistant Profile Among TB Patients From Haut-Ogooué Region Gabon
    Jabar Babatunde Pacome Agbo Achimi Abdul, Paul Snael Eyinghi Openbindjala, Micheska Epola Dibamba Ndanga, Saïdou Mahmoudou, Stredice Manguiga, Tiburce Etele, Arnault Mfoumbi, Audrey Sylviane Imounga, Guy Roger Ndong Atome, Joseph Privat Ondo et al. · 2026 · medRxiv
40. Baseline determinants of adherence for drug-sensitive TB treatment in a South African prospective cohort: a focus on HIV infection and anti-retroviral therapy, clinical care access, and TB stigma
    Adrian Steulet, Piotr Hippner, Noriah Maraba, Lauren Jennings, Israel Rabothata, Rachel Mukora, Nokhanyo Xaba, Lihle Mchunu, Kavindhran Velen, Catherine Orrell et al. · 2026 · BMC Infectious Diseases
41. Prevalence of drug resistant tuberculosis and its associated factors among tuberculosis patients at wolkite health center in central Ethiopia
    Asnake Simieneh, Rahel Dereje, Tadesse Misganaw, Gossa Fetene Abebe · 2026 · Scientific Reports
42. Evaluation of a short, all oral treatment regimen including bedaquiline, delamanid, linezolid, clofazimine, and pyrazinamide named “Regimen C” for pre-XDR tuberculosis in Niger
    Boubacar Marou Soumana, Abdourahamane Yacouba, Cheikh Aboubacar Abdoul Lawi, Ibrahim Oumar, Bassirou Souleymane, A Soumana, Ounoussa Tapha, Mahamadou Doutchi, Mamane Daou, Souleymane Brah et al. · 2026 · Frontiers in Tuberculosis
43. Antimycobacterial activity of intertidal sediment-derived bacteria from False Bay, South Africa
    Funanani Thagulisi, Lucinda Baatjies, Abhinav Sharma, Justice Trésor Ngom, Kudakwashe Nyambo, Tracey Jooste, Kudzanai Ian Tapfuma, Vuyo Mavumengwana · 2026 · Frontiers in Microbiology
44. Mycobacterial Membrane Targeting Synthetic Antimicrobial Peptides For Treatment Against Tuberculosis: A Systematic Review
    Shubhada Milind Khade, Ilanila Ilangumaran Ponmalar · 2026 · Advanced Therapeutics
45. Application of Clinical-Radiomics Fusion Model in Predicting Drug Resistance of Cavitary Pulmonary Tuberculosis
    Chun-Yan Zhao, Chang Song, Zhen-Tao Huang, Xiao-Shi Lin, Xuewen Huang, Shulin Song, Hang-Biao Qiang, Qingdong Zhu, Zhouhua Xie · 2026 · Infection and Drug Resistance
46. Isolation, Structural Characterization and Evaluation of in-vitro Anti-tubercular Activity of Quercetin from Leaves of Tragia involucrata
    M. Thenmozhi, M. Gokul, E. N. T. Vikram, K. Muthukrishnan · 2025 · Toxicology International
47. Automated Tuberculosis Detecon in Chest X-Rays Using Deep Learning Models with Grad-CAM++
    Sunita, Prerna Singal · 2025 · International Conference on Intelligent Systems for Cybersecurity (ISCS)
48. A Novel Triterpene From Erica Miranjiana with Potential Anti-Tubercular Activity
    Carlos Namaona, Kumbukani K. Nyirenda, Kennedy J. Ngwira, Frank Ngonda, Peter Kumpalume · 2026 · Chemistry Africa
49. Artificial Intelligence as an Alternative Strategy for the Rapid TB Detection, Discrimination, and Drug‐Resistance Identification: A Systematic Review and Meta‐Analysis
    Abayeneh Girma, Jemal Abnew, Belaynew Kelkay · 2026 · The Journal of Engineering
50. Drug-resistance profile of Mycobacterium tuberculosis to first-line anti-tuberculosis agents in new and previously treated pulmonary tuberculosis patients from Andhra Pradesh, India
    Anagoni Srikar, BV Ramana, Parnakshi Sarma, Alladi Mohan, Abhijit Chaudhury · 2025 · The Journal of Clinical and Scientific Research
51. NAT2 Acetylation Phenotypes in India: A Narrative Review of Personalized TB Therapy
    Nikhat Khan, Manjari Jonnalagadda, Ravindra Kumar, Aparup Das · 2026 · Pharmacogenomics and Personalized Medicine
52. Comparative evaluation of sputum microscopy and Xpert MTB/RIF assay for tuberculosis detection and rifampicin resistance surveillance in Biratnagar, Nepal
    Shristy Ojha, Akash Adhikari, Sujan Adhikari, Swagat Khanal, Chandan Sah Kalwar, Om Prakash Panta · 2026 · Microbiology Spectrum
53. Mycobacterium tuberculosis antigen-containing exosomes reinforce BCG vaccine efficacy by augmenting long-term protection and memory response against experimental tuberculosis in BALB-C mice
    Manu Sharma, Sher Afghan, Amit Singh, Iqbal Alam, Meetu Agarwal, Mohd Shahid, Shaikh Muhammad Atif, Saif Ahmad Khan, Syed Saima Malik, Vengala Rao Yenuganti et al. · 2026 · Frontiers in Immunology
54. How do social network models compare to all-to-all models for forecasting tuberculosis epidemics? A mathematical modeling study
    Masabho P. Milali, Hae-Young Kim, George F. Corliss, Anna Bershteyn · 2026 · PLoS ONE
55. Molecular mechanisms of immune evasion by host protein glycosylation of a bacterial immunogen used in nucleic acid vaccines
    Mukaddes Sena Cinar, Trevor M. Adams, Fathima Zahra Nawaz, Elif S. Demir, Mariye Erol Demirturk, Aidan P. Keelaghan, Shaima Muhammed Nazaar, Blaine Russell Roberts, Ahmet Ozdilek, Fikri Y. Avci · 2026 · Journal of Biological Chemistry
56. Development and clinical evaluation of new bloodbased tests for improving the diagnosis of pulmonary tuberculosis and identification of candidate biomarkers for treatment monitoring : a multicenter study in moderate and high incidence settings
    Rim Bayaa · 2022 · theses.fr (ABES)
57. Single-cell screening for noise-modulating compounds : an unconventional strategy to tackle antibiotic persistence
    Maxime Mistretta · 2021 · theses.fr (ABES)
58. Synthetic biology and open science : the next frontier of antibiotic discovery and antimicrobial resistance research
    Ayan A. Abukar · 2023 · theses.fr (ABES)
59. Epidémiologie de Tenacibaculum, agents responsables de la ténacibaculose du Platax orbicularis
    Pierre Lopez · 2022
60. Synthesis, Antitubercular Activity, and Computational Characterization of Novel Phenylpyrazole‐Isoniazid Derivatives
    Fernando Carlos Carrasco, Wilfredo Hernández, Juan Zenón Dávalos, Jackeline Mosquera, Oscar Chupayo, Nelly Elena Sivipaucar, Jaime Tamayo, Eduardo Carrasco-S, Jorge Coronel, Osvaldo Yáñez et al. · 2026 · Advances in Pharmacological and Pharmaceutical Sciences
61. Unraveling the Complexities of Coinfection Diagnosis and Treatment
    Monika Singh, N NARESH KUMAR, Sadish Kumar Shanmugam, Moumita Barman · 2026 · BENTHAM SCIENCE PUBLISHERS eBooks
62. A formative evaluation of the TB Think Tank’s role and influence on TB policy in South Africa
    Bey‐Marrié Schmidt, Chanelle Mulopo, Lilian Mayieka · 2026 · PLOS Global Public Health
63. Risk Factors for the Development of Drug-Resistant Tuberculosis: A Retrospective Case-Control Study
    Umesh Chhotala, Niraj Bharadva, Prashant Dave, Pranav Kshtriya, Utkarsh M. Shah · 2026 · SN Comprehensive Clinical Medicine
64. Aptamer-Loaded Cubosome Lipid Nanoparticles for the Treatment of Tuberculosis
    Sampa Sarkar, Tarun Kumar Sharma, Haitao Yu, Brendan Dyett, Andrew S. Ball, Calum John Drummond, Sarvesh Soni, Charlotte E. Conn · 2026 · ACS Applied Materials & Interfaces
65. Real-time bioluminescence imaging of mycobacteria with Akaluc: a novel method for monitoring drug efficacy
    Md Shafiul Islam, Atsuki Takeishi, Yoshitaka Tateishi, Akihito Nishiyama, Yuriko Ozeki, Yutaka Yoshida, Amina Kaboso Shaban, Takeshi Annoura, Satoshi Iwano, Takasuke Fukuhara et al. · 2026 · Scientific Reports
66. Multidrug-resistant tuberculosis: a comprehensive review of pathogenesis, drug resistance, current treatment and future prospects
    Shweta Tiwari, Anjan Kumar Singh, Aarshu Acharya, Joyabroto Ghosh, Rashmi Prabha Singh · 2026 · Archives of Microbiology
67. Combating Pulmonary Tuberculosis: Challenges, Advances, and the Quest for New Therapies
    Poonam Soni, Anvita Gupta Malhotra, Saurabh Sehgal, Alkesh Khurana, Sagar Khadanga, Jitendra Singh · 2026 · Springer eBooks
68. Combating Mycobacterial Infections: An Overview of Therapeutic Strategies
    Aishwarya Shaji, Ashima Bhaskar, Ved Prakash Dwivedi, Amit Singh · 2026 · Springer eBooks
69. Experiences and understanding of diagnosis and treatment among drug-resistant extrapulmonary tuberculosis patients: A qualitative study from Central India
    Gautam Bhagwat, Pavan Asalampuram, Arti Julka, Cecilia Stålsby Lundborg, Manju Raj Purohit · 2026 · PLOS Global Public Health
70. Infectious Disease Provider Perspectives on Shorter Tuberculosis Treatment Regimens
    Aliya Moreira, Dana Hassneiah, Susan E. Beekmann, Philip M. Polgreen, Maunank Shah, Ruvandhi R. Nathavitharana · 2026 · Open Forum Infectious Diseases
71. Herbal supplements and anti-tuberculosis therapy: unlocking hidden interactions for better multidrug-resistant tuberculosis management
    Siva Bhukya, Ravi Adinarayan Somabattini, Neelanjan Chowdhury, Sathi Sarkar, Anish Kumar Das, Kabita Mahato, Korra Hanumu, Satheesh Kumar Nanjappan · 2026 · Drug Metabolism Reviews
72. Novel Anti-Microbial Peptides Design and Screening Against the KatG Using Molecular Docking and MD Simulation
    Kanchan Mehta, Shama Mujawar, Kumar Gaurav, Ashish Vyas · 2026 · Probiotics and Antimicrobial Proteins
73. Molecular modeling and binding interaction analysis of coumarin oxime ether derivatives against mycobacterial dihydrofolate reductase
    Juhi Saraswat, Alok Kumar, Rajan Patel · 2026 · Discover Chemistry.
74. Molecular Interplay of Brucellosis and Tuberculosis: Insights into Telomere Biology, Oxidative Stress, and Drug Resistance Mechanisms
    Fatouma Mohamed Abdoul‐Latif, Rohit Kumar, Yahya Ali Ismael, Houda Mohamed, Ali Mérito, Saber Ali Ahmed, Reetu Yadav, Pannaga Pavan Jutur, Arpana Vibhuti · 2026 · Diseases
75. Retractions in tuberculosis research: analyzing patterns, reasons, and temporal trends from 1993 to 2023
    V M Ravi Kumar, Pragya Anand, Yusuf Akhter · 2026 · Archives of Microbiology
76. Pyrimidine scaffolds in antitubercular drug design: A detailed review of synthesis, SAR, and biological profiles
    Deva, Moksh Shah, Afzal Nagani · 2026 · Journal of Molecular Structure
77. Rapid detection of treatment-emergent resistance to bedaquiline and pretomanid in Mycobacterium tuberculosis using TM4:: GeNL reporter mycobacteriophages
    Senamile L. Ngema, Rajagopalan Saranathan, Rubeshan Perumal, Sashen Moodley, Kevin J. Guzman, Adrie J. C. Steyn, William R. Jacobs, Kogieleum Naidoo, Max O’Donnell, Michelle H. Larsen · 2026 · Microbiology Spectrum
78. Design, Synthesis, and Biological Evaluation of 7-Chloroquinoline Derivatives Against Mycobacterium tuberculosis H37Rv
    Shankar G. Alegaon, J. Chand, Shankar Gharge, R. S. Kavalapure, S. D. Ranade, D. Sriram, M. Singh, N. R. Sutar, G. A. Govind · 2026 · Russian Journal of Bioorganic Chemistry
79. Human resources management for communicable diseases in Afghanistan
    Enayatullah Hayat, Ali Mohammad Mosadeghrad · 2026 · Human Resources for Health
80. Multidrug resistant tuberculosis (MDR-TB) in Eritrea: a retrospective cohort analysis of mortality and associated factors (2013 – 2023)
    Hagos Andom Teumezgi, N. N. Suud, Yohannes Mehari Berhane, Saleh Mohammed Said, Daniel Tesfagherghish Hailu, Kidane Kifle Habtetsion, Tekie Merawi Weldetnsae, Oliver Okoth Achila · 2026 · Frontiers in Cellular and Infection Microbiology
81. Bioinspired peptide cyclisation enables exploration of cytochrome P450 catalysed sequential oxidation in rufomycin biosynthesis
    Jessica Peate, Yaoyu Ding, J. P. Tomkins, Harry R. Winter, Jingwen Zhang, Cameron M. L. Coleman, Priya Solanki, Jake H. Nicholson, Toby Hopkinson, Gustavo Pérez-Ortíz et al. · 2026 · Chemical Science
82. Therapeutic drug monitoring of anti-tubercular drug through saliva: An alternative approach
    Utpal Bhui, Joy Das, Gouri Shankar Chakraborty, Bimlesh Kumar, Sushama Verma · 2026 · AIP conference proceedings
83. Repurposing potential of cell wall modulating drugs: A new frontier in TB management
    Sana Jamily, Sarah Hamid, Faizan Ansari, Vikas Kumar, Sonam Grover · 2026 · Elsevier eBooks
84. Prevalence and Factors Associated with Drug Resistance Among Pulmonary Tuberculosis Patients in a District of North Kerala
    Suhail Neliyathodi, Dr. Jinsha Ap · 2026 · Galore International Journal of Health Sciences and Research
85. Environmentally benign synthesis, characterization, and in vitro anticancer and anti-TB activity of indolizines, along with anti-TB and anticancer docking studies
    Vishnu Chavhan, B M Gurupadayya, Basavaraj Padmashali · 2026 · Letters in Drug Design & Discovery
86. The MEG3/miR-133b regulatory axis in exosomes influences macrophage responses to drug-resistant mycobacterium tuberculosis
    Chuanqi Zou, Boxin Wang, Chengguang Wang, Jingjin Ma, Xinyu Yang, Junhong Chen, Zhengxue Quan, Wenjie Wu · 2026 · Archives of Microbiology
87. An overview of bioinformatics approaches to understand drug resistance and identifying novel inhibitors against multidrug-resistant Mycobacterium tuberculosis
    Elizabeth Annie George, Mahima Senthilkumar, Kavitha Thirupugazh, Shivani Rajesh, Mahasaraswathi Chockalingam, Sudha Ramaiah, Anand Anbarasu · 2026 · Beni-Suef University Journal of Basic and Applied Sciences
88. The Future of Vaccines and Vaccine Confidence
    Madelyn Moulton, Soneet Dhillon, Archana Chatterjee · 2026 · Springer eBooks
89. Free energy perturbation and machine learning-assisted identification of novel molecules for the Mycobacterium tuberculosis KasA protein: a fragment-based drug design approach
    Md Ataul Islam, Mohammad Ajmal Ali, Rupesh V. Chikhale, Md Ataul Islam, Mohammad Abul Farah · 2026 · Molecular Diversity
90. Single-step Sintered 3D-printed Fixed-dose Combined Bilayer Tablets for Compartmentalized Delivery of First-line Anti-tubercular Drugs
    Tukaram Ram Karanwad, Saurabh Bodake, Sachin B. Jorvekar, Santa Mandal, Roshan M. Borkar, Subham Banerjee · 2026 · The AAPS Journal
91. Single-Cell Measurement Revolution: A New Paradigm in Tuberculosis Diagnosis
    Dianmo Ni, Gang Liu · 2026 · ACS Measurement Science Au
92. Epidemiology, Associated Factors, Rifampicin Resistance, and Cytological Findings of Extrapulmonary Tuberculosis among Presumptive Patients at Mehal Meda General Hospital, Ethiopia: A Retrospective Cross-Sectional Study
    Mihret Tilahun, Agumas Shibabaw, Chernet Belayhun · 2026 · Research Square
93. Comprehensive pulmonary rehabilitation for post-tuberculosis lung disease: a narrative review
    Rui Li, Kai Ling Chin, Qiuyi Li, Yaxi Zhao, Yang Yang, Luís Anibarro, Ana Chouza Piñeiro, María Elena Cardoso Sarmiento, Armando Acosta · 2026 · Frontiers in Medicine
94. Comparison of Tuberculin Skin Test and Interferon-Gamma Release Assay for Latent Tuberculosis Screening in Healthcare Workers
    Khalid Alrajhi, Ahmad Algarni, Walaa Abulola, Abdulaziz Alhadad, Saja Fallatah, Mariam Alrajhi, Arwa Ghasib, Hanan Fan, Yusuf Vali · 2026 · Cureus
95. Computational introspection of impact of mutation A90V and A90E in DNA gyrase a of Mycobacterium tuberculosis in developing resistance against Delafloxacin
    Sumit Kumar Rai, Dev Bukhsh Singh, Pramod Kumar Yadav, Sapna Pandey, Satendra Singh · 2026 · Brazilian Journal of Microbiology
96. Structure–Thermodynamics–Biointerface Correlations in Trimetallic Au–Pt–Pd Nanofluids with Antimycobacterial Activity
    Amit Dubey · 2026 · Journal of Molecular Structure
97. Rapid simultaneous detection of katG S315T and rpoB S531L mutations for molecular screening of multidrug-resistant tuberculosis using a dual LAMP-lateral flow assay
    Jutturong Ckumdee, Somchai Santiwatanakul, Nakarin Vutipow, Thongchai Kaewphinit · 2026 · Microbiology Spectrum
98. Gpr84 activation induces anti-mycobacterial defense in macrophages via MAPK signaling
    Seoyeon Jo, Junghwan Lee, Jaewhan Kim, Jiae Choi, Doan Tam Nguyen, Subin Choi, Chang-Hwa Song · 2026 · Immunobiology
99. Quantum Chemical Simulations, Molecular Docking and Molecular Dynamics Identify Garlic‐Derived Phytocompounds as Computationally Prioritized Candidates Against Mycobacterium tuberculosis
    Erik George, Aniket Naha, Pragasam Viswanathan, Saravanan Natarajan, Sudha Ramaiah, Anand Anbarasu · 2026 · ChemistrySelect
100. Tuberculosis of the Spine in Children- Is Non-operative Treatment Effective?
     TausifAhmed A. Shikalgar, Arjun A. Dhawale, Ira Shah, Bhushan Sagade, Deepika Pinto, Shubhanshu Bhaldhare, Sarang Rokade, Alaric John Aroojis, Rujuta Mehta, Abhay Nene · 2026 · North American Spine Society Journal (NASSJ)